Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

ADKB

Species Cat.# Product name Source (Host) Tag Protein Length Price
Zebrafish ADKB-9837Z Recombinant Zebrafish ADKB Mammalian Cell His
  • Involved Pathway
  • Protein Function
  • Interacting Protein

ADKB involved in several pathways and played different roles in them. We selected most pathways ADKB participated on our site, such as Purine metabolism, Metabolic pathways, which may be useful for your reference. Also, other proteins which involved in the same pathway with ADKB were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.

Pathway Name Pathway Related Protein
Purine metabolismPRIM2;ENTPD2;ENTPD2A.1;TM9SF1;PNP5B;CANT1B;NT5C2B;POLR2B;NPR1A
Metabolic pathwaysUGT1A6B;NDUFV1;CYP4F2;UGT2B7;GALNTL2;SPTLC2B;MVK;AOX3L1;ADH2-2

ADKB has several biochemical functions, for example, adenosine kinase activity, kinase activity, phosphotransferase activity, alcohol group as acceptor. Some of the functions are cooperated with other proteins, some of the functions could acted by ADKB itself. We selected most functions ADKB had, and list some proteins which have the same functions with ADKB. You can find most of the proteins on our site.

Function Related Protein
adenosine kinase activityADKB;ADKA;ADK
kinase activityFYNA;PRPS2;RPS6KA3B;CAMK1DA;CAMKK1A;PTK2AB;IGF1RA;LRGUK;CLK4B
phosphotransferase activity, alcohol group as acceptorPI4KAB;FAM20B;POMK;G6PC;FGGY;GKUP;ADKB;PI4KAP2;SMG1
transferase activityZDHHC18B;BMPR1AB;ST6GALNAC5B;CEPT1B;GOT2B;DNAJC3B;FUT9A;ELOVL7B;CHST2A

ADKB has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with ADKB here. Most of them are supplied by our site. Hope this information will be useful for your research of ADKB.

  • Q&As
  • Reviews

Q&As (15)

Ask a question
What other diseases could be treated with ADKB inhibitors? 12/02/2022

ADKB inhibitors are being investigated for a variety of other diseases, including cardiovascular disease, neurological disorders, and metabolic disorders such as diabetes. For example, studies have shown that ADKB inhibitors can improve glucose metabolism and insulin sensitivity in animal models of diabetes. Additionally, ADKB has been implicated in the development of neurodegenerative diseases such as Alzheimer's and Parkinson's disease, and ADKB inhibitors are being tested as potential treatments for these conditions.

Is ADKB a druggable target? 08/12/2022

Yes, ADKB is considered a druggable target, meaning that it can be targeted with small molecule drugs. Several ADKB inhibitors have been developed and are currently being tested in preclinical and clinical studies for a variety of conditions. However, further research is needed to determine the efficacy and safety of these inhibitors for different diseases.

Are there any natural ADKB inhibitors? 10/25/2021

Yes, there are some natural products that have been shown to inhibit ADKB. These include curcumin, a compound found in turmeric, and resveratrol, a compound found in grapes and red wine. However, the levels of ADKB inhibition achieved with these natural products may not be as potent as those achieved with synthetic inhibitors, and further research is needed to determine their efficacy as ADKB inhibitors.

Are there any side effects associated with ADKB inhibitors? 09/01/2020

Yes, like all medications, ADKB inhibitors can have side effects. The specific side effects can vary depending on the inhibitor used, the dose, and the individual's response to the medication. Common side effects of ADKB inhibitors can include nausea, vomiting, diarrhea, fatigue, and muscle cramps. In some cases, ADKB inhibitors can also cause more serious side effects such as blood disorders, liver damage, and heart problems.

Can ADKB be used as a biomarker for mitochondrial disorders? 04/20/2020

ADKB levels have been found to be decreased in patients with mitochondrial disorders, suggesting that it may be a useful biomarker for these conditions. However, further research is needed to determine its specificity and sensitivity as a diagnostic marker.

How are ADKB inhibitors administered? 11/16/2019

ADKB inhibitors can be administered orally in the form of pills or capsules. In some cases, they may also be administered intravenously (through an IV infusion). Dosage and administration will vary depending on the specific inhibitor and the condition being treated. It is important to follow the instructions of a healthcare provider when taking ADKB inhibitors, and to report any potential side effects or concerns promptly.

Are ADKB inhibitors effective for all types of cancer? 06/15/2019

No, ADKB inhibitors are not effective for all types of cancer. They are most commonly used to treat certain types of leukemia and solid tumors such as gastrointestinal stromal tumors (GISTs). However, ADKB inhibitors are not effective for all cases of these cancers, and they may not be effective for other types of cancer. The use of ADKB inhibitors in cancer treatment is an area of ongoing research and development.

Are there any FDA-approved ADKB inhibitors? 09/29/2018

Yes, there are currently FDA-approved drugs that act as ADKB inhibitors. These include Imatinib (Gleevec) and Dasatinib (Sprycel), which are both used to treat certain types of leukemia. These drugs were initially developed as inhibitors of a different kinase, but were found to also inhibit ADKB. However, their use as ADKB inhibitors for other conditions is still being investigated in preclinical and clinical studies.

Is ADKB involved in neurological disorders? 04/28/2018

Yes, ADKB has been linked to several neurological disorders, including Parkinson's disease and Alzheimer's disease. Studies have shown that ADKB levels are decreased in the brains of patients with these conditions, suggesting that it may play a role in their pathogenesis. Additionally, ADKB has been shown to regulate the dynamics of mitochondria in neurons, which is critical for neuronal function.

How is ADKB related to cancer? 03/18/2018

ADKB expression has been found to be dysregulated in several types of cancer, including breast, prostate, and pancreatic cancer. It has been shown to promote cancer cell survival and proliferation by regulating energy metabolism and signaling pathways. ADKB inhibitors have been developed as potential anticancer agents, and some have shown efficacy in preclinical models.

Can ADKB inhibitors be used as a therapeutic strategy for cancer? 11/01/2017

ADKB inhibitors have been studied as a potential therapeutic strategy for cancer, particularly in combination with other therapies such as chemotherapy or radiation therapy. They have shown promise in preclinical models by inhibiting cancer cell growth and inducing cell death. However, further research is needed to determine their safety and efficacy in clinical trials.

Can ADKB be targeted for metabolic disorders? 09/29/2017

Yes, ADKB has been identified as a potential therapeutic target for metabolic disorders such as obesity and type 2 diabetes. Studies have shown that ADKB levels are elevated in the skeletal muscle of obese individuals and that ADKB inhibitors can improve insulin sensitivity in animal models of type 2 diabetes. Further research is needed to determine the efficacy of ADKB inhibitors for these conditions in human studies.

Are ADKB inhibitors being studied for other conditions besides cancer? 07/28/2017

Yes, ADKB inhibitors have potential applications for a variety of conditions beyond cancer. For example, they have been studied as a potential treatment for sickle cell anemia, which involves the destruction of red blood cells and reduced oxygen transport. ADKB inhibitors have been shown to increase the production of a molecule called 2,3-BPG, which can improve the oxygen transport capacity of red blood cells.

Can ADKB inhibitors cause side effects? 06/18/2017

Yes, like all drugs, ADKB inhibitors can cause side effects. The specific side effects can vary depending on the drug and the dose used. Common side effects include nausea, vomiting, diarrhea, fatigue, and skin rash. More serious side effects can also occur, such as liver toxicity, fluid retention, and cardiovascular events. It is important to discuss the potential side effects with a healthcare provider before starting treatment with an ADKB inhibitor.

Can ADKB inhibitors be used to treat cancer? 05/06/2017

Yes, ADKB inhibitors have been investigated as potential cancer treatments. ADKB plays a role in promoting the growth and survival of cancer cells, particularly in certain types of leukemia and solid tumors. Inhibiting ADKB can lead to decreased cancer cell growth and increased cell death. Imatinib and Dasatinib, which were mentioned earlier, are commonly used as ADKB inhibitors in the treatment of leukemia.

Customer Reviews (3)

Write a review
Reviews
07/06/2022

    I believe this protein will meet all of my experimental needs.

    11/10/2020

      It is highly pure and shows excellent activity in my assays.

      07/19/2017

        the manufacturer's technical support team has been incredibly helpful and responsive, providing me with excellent support that has solved any issues I encountered during my experiments.

        Ask a Question for All ADKB Products

        Required fields are marked with *

        My Review for All ADKB Products

        Required fields are marked with *

        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /

        Stay Updated on the Latest Bioscience Trends